INTRODUCTION
Warm autoimmune hemolytic anemia (WAHA) is known to occur in association with lymphoid malignancies and ovarian teratomas. No consistent association between WAHA and carcinoma has been demonstrated. Hemolytic anemia has been reported to occur in some patients with ovarian carcinoma, but in no case has the hemolysis been produced by a warm autoantibody. Although paraproteins are found in lymphoproliferative diseases, no clear association exists between the occurrence of monoclonal proteins and solid tumors. We report a patient with a pure seminoma who developed severe IgG-mediated WAHA, monoclonal 1gM-kappa cryoglobulinemia and a biological false positive test for syphilis. These antibodies disappeared following treatment of the tumor and the hemolytic anemia.
CASE REPORT
In February 1973, when he was 34 years old, the patient noted enlargement of his right testicle. In March 1973 he suffered from dizzy spells and weakness and he was noted to be pale. There was a history of a congenital hydrocele of the right testis but no cryptorchidism. He had a low grade fever but no night sweats, weight loss, skin rash or Raynaud's phenomenon. There was no history of drug usage or blood loss and no prior or family history of anemia.
On examination he was pale, with a temperature of 1010F, pulse 100/min, and blood pressure 110/70 mm Hg. The skin was clear, but there was a trace of scleral icterus. There was no lymphadenopathy. A grade II /VI cardiac ejection murmur was present. The liver was palpable five centimeters below the right costal margin and the spleen tip was twelve centimeters at the level of the umbilicus. There was a small hydrocele of the left testis. A large hydrocele was present in the right testis and, in addition, a hard, irregular mass was felt fixed to the scrotum in the midline.
The The chest x-ray was normal. Lymphaniogram revealed enlargement and architectural derangement of the lymph nodes in the abdomen. Bone density was generally increased. Liver-spleen scan revealed hepatosplenomegaly but no focal abnormalities.
Blood transfusions were given despite an inability to find compatible crossmatches, because of the severity of the anemia. The changes in clinical course and laboratory tests following therapy are depicted in Fig. 1 . Prednisone was given orally, first at 100, then at 150 mg/day. 250 cc of serosanguineous fluid were removed from the hydrocele, but a 2 x 1 cm mass remained in the right testis. A right orchiectomy was performed. The tumor was a pure seminoma with a few areas of lymphoid proliferation (Fig. 2) . There was no blood vessel or spermatic cold involvement. In comparison with other seminomas this lymphoid infiltrate was not marked [1] . Anemia persisted and further blood transfusions were given. One week later external radiation was delivered to the spleen, but this produced no significant reduction of its size. Because of the malignant testicular tumor, the large abdominal lymph nodes and the possibility of marrow involvement, the patient was considered to have metastatic seminoma. As treatment for this, he was started on systemic chemotherapy with cyclophosphamide (1 gm/M2 q 3-4 weeks) and vincristine (1.4 mg/M2 weekly) two days after the end of the radiation to the spleen. After two more weeks there was a marked reticulocytosis, improvement of anemia, diminution of the direct antiglobulin score, and transient increase in the white count. The hematocrit again began to fall, and the leukopenia (3,200/mm3) and thrombocytopenia (170,000/mm3) recurred. Splenectomy was then performed.
The spleen was massively enlarged (1500 gms) and microscopically showed passive congestion and extramedullary hematopoiesis, but no tumor was found. The liver and lymph nodes were also histologically free of tumor. Immediately after the splenectomy, the white blood cell count rose to 14,000/mm3, the platelet count to 700,000/mm3 and the hematocrit to 52%. Prednisone was stopped. A repeat marrow aspirate showed only erythroid hyperplasia. Three months after the orchiectomy, the direct and indirect antiglobulin tests were negative and the VDRL and monoclonal cryoglobulin were no longer demonstrable. Hemolysis never recurred. The patient received additional chemotherapy for one and one-half years because of the uncertainty over the extent of the tumor. The lymphangiographically abnormal abdominal lymph nodes may have represented either lymphoid hyperplasia or seminoma that had already responded to the chemotherapy by the time of the laporotomy. The patient is now asymptomatic, off all treatment for two years with no recurrence of tumor, hemolysis or paraproteinemia. DISCUSSION Our patient developed symptomatic anemia shortly after he noted progressive testicular enlargement from a seminoma. The hemolytic anemia resulted from a warm IgG auto-antibody, which reacted as a panagglutinin, fixed complement and caused red cell destruction predominantly in the spleen. Hypersplenism, which in this case probably resulted from a passively congested spleen, was reversed by splenectomy. The severity of the hemolytic anemia and the uncertainty over the extent of spread of the seminoma necessitated the use of several therapeutic modalities and, therefore, obscured the response to each individual maneuver. The treatments utilized that could have independently affected the course of the hemolytic anemia included orchiectomy, therapeutic steroids, splenic irradiation, chemotherapy, and splenectomy. The sequence of these treatments and the hematologic responses are depicted in Fig. 1 . It is conceivable that the orchiectomy alone may have influenced the production of antibody and therefore hemolysis, but this is impossible to ascertain.
Although anemia in patients with malignant disease is usually related to more than one factor, hemolysis alone can sometimes be its cause. Shortened 51Cr red cell survival has been identified in patients with cancer without overt hemolytic anemia [2] . Significant hemolysis is more likely to develop as the malignancy becomes more advanced [3] . Overt hemolytic anemia, however, remains rare: clinical hemolysis was found in only 3% of anemic patients with carcinoma [2, 4] . The majority of these hemolytic anemias are negative to direct antiglobulin testing (DAT) [4, 5, 6] . These microangiopathic hemolytic anemias are associated with mucin-producing adenocarcinomas, many involving the bone marrow [6, 7, 8] , and demonstrate prominent red cell fragmentation, intravascular fibrin deposition, and fibrinogen and platelet consumption [9, 10] . While antibody-mediated hemolytic anemia can develop in several malignancies, it is most common in the lymphoproliferative syndromes, such as chronic lymphocytic leukemia and the lymphomas [11] . These [14] reported positive DATs in 39% of 393 patients with carcinoma. This high frequency has not been supported by subsequent reports. For example, Shen et al [4] found no positive DAT's in 116 anemic cancer patients, and only one of 34 patients with cancer and hemolytic anemia reported by Hyman et al [5] was DAT positive. In an extensive review of red cell autosensitization [15] , only 20 patients with carcinoma had WAHA. In four of these patients the cancer and the WAHA were clearly associated. Removal of a renal cell carcinoma in one of these patients was followed by the cessation of hemolysis and disappearance of the antibody [16] . Additional cases have been reported of WAHA occurring together with a variety of carcinomas, but no consistent pattern has emerged [3, [17] [18] [19] [20] ].
An association between various ovarian tumors and hemolytic anemia first described in 1938 [21] seems to be especially pertinent to our case. Unfortunately, the syndrome has been mistakenly generalized to include both benign and malignant ovarian tumors and hemolytic anemias of diverse etiology [22] . There The six patients reported to have simply "hemolytic anemia" in association with "ovarian carcinoma" [22, [30] [31] [32] [33] [34] have followed no consistent pattern. In none of these cases was the hemolysis clearly mediated by a warm autoantibody. These reports and the mechanisms of hemolysis are summarized in Table 1 to demonstrate how they clearly differ from the syndrome of WAHA and ovarian teratoma. In two of the patients the antibodies found were isoantibodies [30, 32] . One of these patients [32] was thought to have WAHA, but the course was typical of a delayed hemolytic transfusion reaction [35] . The patient reported by Andre et al [33] developed hemolytic anemia with a positive DAT. The antibody, however, was an IgM anti-I, serologically distinct from WAHA. In one patient, a potent hemolysin was identified, but it had no antibody activity [34] .
In addition to the transient WAHA, monoclonal IgM-kappa cryoglobulin and a biological false positive test for syphilis were also present in our patient. There was no evidence for multiple myeloma and no symptoms (such as purpura, urticaria, or Raynaud's phenomenon) resulted from the cryoglobulin. In patients with carcinoma neither cryoglobulins [36] nor monoclonal immunoglobulins [37] occur with the increased frequency found in patients with lymphoid malignancies [36, 38] . However, of those patients with "benign" monoclonal proteins, many have a carcinoma, suggesting a relationship between the two [39, 40] . Treatment of a localized tumor has occasionally resulted in the disappearance of the monoclonal globulin [41] . Cryoglobulinemia can be associated with hemolytic anemia in patients with cold agglutinin disease [36] but it could not explain the WAHA in our patient.
The production of red cell autoantibody, monoclonal cryoglobulin and falsely positive test for syphilis were all transient immunological phenomena here, which may well have occurred in response to the seminoma. The stimulus for autoantibody production in a patient with a tumor is uncertain. Three mechanisms have been generally postulated for the production of red cell autoantibodies: antibodies produced to tumor-associated antigens that cross-react with red cell antigens, antibodies produced to red cell antigens altered by the tumor or antibodies produced by lymphoid elements within the tumor. However, rather than invoking such unproved local effects of the tumor, it seems equally plausible to attribute the syndrome to a systemic alteration of immunity induced by the tumor, as supported here by the presence of a variety of antibodies. This-phenomenon of multiple antibody produc-tion has also been seen in the ovarian teratoma-WAHA syndrome [11] . WAHA can occur with illnesses of very different etiology (collagen disease, lymphoproliferative disease, ovarian teratoma, alpha-methyl-DOPA administration), but the serology in all of these instances is the same. The basis of the response in the whole group may be a systemic alteration of immunity, with a resultant rather uniform pattern of autoantibody production. The exact immunological alterations caused by the tumor to account for the syndrome, such as an increase in the number of "helper" T-cells [42] or a decrease in "suppressor" cells [43] , remain to be determined.
